TY - JOUR KW - Adolescent KW - Adult KW - Age Factors KW - Aged KW - Child KW - Cohort Studies KW - Cross-Sectional Studies KW - Ethiopia KW - Female KW - Hepacivirus KW - Hepatitis Antibodies KW - Hepatitis C KW - Hepatitis C Antibodies KW - Humans KW - Immunoenzyme Techniques KW - leprosy KW - Male KW - Middle Aged KW - Nervous System Diseases KW - Prevalence KW - Risk Factors KW - Rural Population KW - Skin Diseases KW - Urban Population AU - Frommel D AU - Tekle-Haimanot R AU - Berhe N AU - Aussel L AU - Verdier M AU - Preux P M AU - Denis F AB -

Antibodies to hepatitis C virus (HCV) were measured in 1,580 Ethiopian subjects representing urban and rural populations. Sera found positive by a repeated second generation enzyme immunoassay (EIA) were subjected to three additional confirmatory tests. The overall confirmed seroprevalence was 2.0%. Less than 1% were confirmed to be seropositive in rural communities, with 1.4% positive among blood donors, 1.6% positive among patients with dermatologic disorders, 3.6% among leprosy patients, and 6.0% among patients attending a University Hospital clinic for neurologic disorders. The patients in the groups with leprosy and neurologic disorders have most likely been in ill health for many years and have sought relief by traditional healers or treatment at poorly equipped clinics. This group of patients demonstrated a high prevalence of antibodies to HCV. In Ethiopia, especially in small clinics, there is a shortage of syringes and needles and they have to be reused many times often with inadequate sterilization. Therefore, these syringes and needles may be contaminated, thus being a risk factor for HCV and HIV infection.

BT - The American journal of tropical medicine and hygiene C1 - http://www.ncbi.nlm.nih.gov/pubmed/7692753?dopt=Abstract DA - 1993 Oct DO - 10.4269/ajtmh.1993.49.435 IS - 4 J2 - Am. J. Trop. Med. Hyg. LA - eng N2 -

Antibodies to hepatitis C virus (HCV) were measured in 1,580 Ethiopian subjects representing urban and rural populations. Sera found positive by a repeated second generation enzyme immunoassay (EIA) were subjected to three additional confirmatory tests. The overall confirmed seroprevalence was 2.0%. Less than 1% were confirmed to be seropositive in rural communities, with 1.4% positive among blood donors, 1.6% positive among patients with dermatologic disorders, 3.6% among leprosy patients, and 6.0% among patients attending a University Hospital clinic for neurologic disorders. The patients in the groups with leprosy and neurologic disorders have most likely been in ill health for many years and have sought relief by traditional healers or treatment at poorly equipped clinics. This group of patients demonstrated a high prevalence of antibodies to HCV. In Ethiopia, especially in small clinics, there is a shortage of syringes and needles and they have to be reused many times often with inadequate sterilization. Therefore, these syringes and needles may be contaminated, thus being a risk factor for HCV and HIV infection.

PY - 1993 SP - 435 EP - 9 T2 - The American journal of tropical medicine and hygiene TI - A survey of antibodies to hepatitis C virus in Ethiopia. VL - 49 SN - 0002-9637 ER -